Journal profile · BIOPHYSICS-MATERIALS SCIENCE, BIOMATERIALS
Biointerphases
ISSN 1934-8630 · eISSN 1559-4106 · Springer Berlin Heidelberg · UNITED STATES · Founded 2006
Biointerphases: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.71; fully open access; median 96 days to acceptance (71 articles, last 24 months); community-reported acceptance: fairly easy; 52 articles in 2025; indexed in SCIE and Scopus; the journal's website says submissions are paused or closed.
The journal's website says submissions are paused or closed: Biointerphases is now archived and no longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites. Source ↗Publisher website ·
Scope
Aims, scope and focus
Biointerphases is published by Springer Berlin Heidelberg and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Polymer Surface Interaction Studies, Bone Tissue Engineering Materials and Lipid Membrane Structure and Behavior, together about 28.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Biointerphases is no longer published by Springer as of the end of 2013. The journal will continue in cooperation with a new publisher, the American Institute ...
From the journal's Aims & Scope
Research area (LetPub): BIOPHYSICS-MATERIALS SCIENCE, BIOMATERIALS
Main research topics OpenAlex counts of recent articles; shares are approximate
- Polymer Surface Interaction StudiesMaterials Science14.7%
- Bone Tissue Engineering MaterialsEngineering7.2%
- Lipid Membrane Structure and BehaviorBiochemistry, Genetics and Molecular Biology6.7%
- Ion-surface interactions and analysisEngineering6.4%
- Force Microscopy Techniques and ApplicationsPhysics and Astronomy5.7%
- 3D Printing in Biomedical ResearchEngineering5.4%
- Advanced biosensing and bioanalysis techniquesBiochemistry, Genetics and Molecular Biology4.8%
- Electrospun Nanofibers in Biomedical ApplicationsMaterials Science4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biophysics | Zone 4 |
| Minor | Materials Science, Biomaterials | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biophysics | Zone 4 |
| Minor | Materials Science, Biomaterials | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biophysics | Zone 4 |
| Minor | Materials Science, Biomaterials | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.71LetPub ·
- CiteScore 2026-06
- 3.3LetPub ·
- SJR 2026-06
- 0.36LetPub ·
- SNIP 2026-06
- 0.45LetPub ·
- h-index
- 32LetPub ·
- h-index
- 71OpenAlex ·
- i10-index
- 631OpenAlex ·
- 2-year mean citedness
- 1.77OpenAlex ·
- Self-citation rate
- 5.6%LetPub ·
- Share of gold OA articles
- 21.32%LetPub ·
Volume
- Articles per year
- 48LetPub ·
Articles by year OpenAlex count · 1,118 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 21 | 3 | 7 |
| 2025 | 52 | 14 | 75 |
| 2024 | 41 | 17 | 120 |
| 2023 | 48 | 21 | 329 |
| 2022 | 39 | 9 | 401 |
| 2021 | 39 | 22 | 371 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
96 daysMedian, submission to acceptance · P25–P75 66 days – 118 days
- Acceptance to online
- —
- Submission to online
- —
- Sample
- 71 articles with submission and acceptance dates (72 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Springer Berlin Heidelberg
- Country or region
- UNITED STATES
- Language
- English
- Founded
- 2006
- ISSN
- 1934-8630
- Electronic ISSN
- 1559-4106
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Biointerphases
What CAS zone is Biointerphases in?
In the 2025 upgraded edition of the CAS Journal Ranking, Biointerphases is in Zone 4 of Medicine, and in Zone 4 of the minor category Biophysics / Materials Science, Biomaterials. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Biointerphases?
The latest impact factor listed by LetPub is 1.71; CiteScore 3.3, h-index 71.
How long does peer review take at Biointerphases?
Based on the dates recorded on 71 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 96 days (interquartile range 66–118 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Biointerphases?
According to LetPub and DOAJ records, Biointerphases is indexed in SCIE and Scopus.
Is Biointerphases open access, and what is the APC?
Biointerphases is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .